Literature DB >> 21157579

Canadian Digestive Health Foundation Public Impact Series. Inflammatory bowel disease in Canada: Incidence, prevalence, and direct and indirect economic impact.

Richard N Fedorak1, Karen Wong, Ron Bridges.   

Abstract

The Canadian Digestive Health Foundation initiated a scientific program to assess the incidence, prevalence, mortality and economic impact of digestive disorders across Canada in 2009. The current article presents the updated findings from the study concerning inflammatory bowel diseases - specifically, Crohn's disease and ulcerative colitis.

Entities:  

Mesh：

Year:  2010        PMID： 21157579      PMCID： PMC3004417          DOI： 10.1155/2010/407095

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN： 0835-7900            Impact factor:   3.522


  9 in total

1.  Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006.

Authors:  Oren Abramson; Michael Durant; William Mow; Allen Finley; Pratima Kodali; Anthony Wong; Venessa Tavares; Erin McCroskey; Liyan Liu; James D Lewis; James E Allison; Nicole Flowers; Susan Hutfless; Fernando S Velayos; Geraldine S Perry; Robert Cannon; Lisa J Herrinton
Journal:  J Pediatr       Date:  2010-04-18       Impact factor: 4.406

2.  Why patients with inflammatory bowel disease use or do not use complementary and alternative medicine: a Canadian national survey.

Authors:  Feng X Li; Marja J Verhoef; Allan Best; Anthony Otley; Robert J Hilsden
Journal:  Can J Gastroenterol       Date:  2005-09       Impact factor: 3.522

3.  The epidemiology of inflammatory bowel disease in Canada: a population-based study.

Authors:  Charles N Bernstein; Andre Wajda; Lawrence W Svenson; Adrian MacKenzie; Mieke Koehoorn; Maureen Jackson; Richard Fedorak; David Israel; James F Blanchard
Journal:  Am J Gastroenterol       Date:  2006-07       Impact factor: 10.864

Review 4.  Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies.

Authors:  Tine Jess; Michael Gamborg; Pia Munkholm; Thorkild I A Sørensen
Journal:  Am J Gastroenterol       Date:  2007-03       Impact factor: 10.864

Review 5.  New global map of Crohn's disease: Genetic, environmental, and socioeconomic correlations.

Authors:  Michael Economou; Georgios Pappas
Journal:  Inflamm Bowel Dis       Date:  2008-05       Impact factor: 5.325

6.  Meta-analysis: mortality in Crohn's disease.

Authors:  C Canavan; K R Abrams; J F Mayberry
Journal:  Aliment Pharmacol Ther       Date:  2007-04-15       Impact factor: 8.171

7.  Overall and cause-specific mortality in Crohn's disease: a meta-analysis of population-based studies.

Authors:  Dana Duricova; Natalia Pedersen; Margarita Elkjaer; Michael Gamborg; Pia Munkholm; Tine Jess
Journal:  Inflamm Bowel Dis       Date:  2010-02       Impact factor: 5.325

8.  Epidemiology of Crohn's disease in Québec, Canada.

Authors:  Anne-Marie Lowe; Pierre-Olivier Roy; Michel B-Poulin; Pascal Michel; Alain Bitton; Laurie St-Onge; Paul Brassard
Journal:  Inflamm Bowel Dis       Date:  2009-03       Impact factor: 5.325

9.  The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States.

Authors:  Michael D Kappelman; Sheryl L Rifas-Shiman; Ken Kleinman; Dan Ollendorf; Athos Bousvaros; Richard J Grand; Jonathan A Finkelstein
Journal:  Clin Gastroenterol Hepatol       Date:  2007-09-29       Impact factor: 11.382
  9 in total
  6 in total

Review 1.  Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: a review.

Authors:  Ammar Hassanzadeh Keshteli; Vickie E Baracos; Karen L Madsen
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

2.  Suppression of methionine-induced colon injury of young rats by cysteine and N-acetyl-L-cysteine.

Authors:  Marija Stojanović; Ljiljana Šćepanović; Dušan Todorović; Dušan Mitrović; Vuk Šćepanović; Radomir Šćepanović; Slobodan Ilić; Teja Šćepanović; Milica Labudović Borović; Živana Milićević; Vesna Dragutinović; Sunčica Borozan; Ivana Lalić; Sanja Despotović; Dragan Djuric
Journal:  Mol Cell Biochem       Date:  2017-08-17       Impact factor: 3.396

Review 3.  5-HT7 receptor signaling: improved therapeutic strategy in gut disorders.

Authors:  Janice J Kim; Waliul I Khan
Journal:  Front Behav Neurosci       Date:  2014-12-11       Impact factor: 3.558

4.  Real-Life Treatment Paradigms Show Adalimumab Is Cost-Effective for the Management of Ulcerative Colitis.

Authors:  Candace L Beilman; Nguyen Xuan Thanh; Victoria Ung; Christopher Ma; Karen Wong; Karen I Kroeker; Thomas Lee; Haili Wang; Arto Ohinmaa; Phil Jacobs; Brendan P Halloran; Richard N Fedorak
Journal:  Can J Gastroenterol Hepatol       Date:  2016-10-03

5.  The Frequency of Clinic Visits Was Not Associated with Medication Adherence or Outcome in Children with Inflammatory Bowel Diseases.

Authors:  Cheryl Kluthe; Jenkin Tsui; Donald Spady; Matthew Carroll; Eytan Wine; Hien Quoc Huynh
Journal:  Can J Gastroenterol Hepatol       Date:  2018-02-25

6.  Characterization of Serotonin Signaling Components in Patients with Inflammatory Bowel Disease.

Authors:  Md Sharif Shajib; Usha Chauhan; Salman Adeeb; Yeshale Chetty; David Armstrong; Smita L S Halder; John K Marshall; Waliul I Khan
Journal:  J Can Assoc Gastroenterol       Date:  2018-08-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.